Consumo E Gastos Com Medicamentos Do Componente Especializado Da Assistência Farmacêutica No Brasil No Período De 2012 a 2021

Bibliographic Data

ID16878552
AuthorsPatrícia Silva Bazoni (0000-0002-3829-4900, Universidade Federal do Rio Grande do Norte), Ronaldo José Faria (0000-0003-0650-128X, Universidade Federal do Espírito Santo), Jéssica Barreto Ribeiro Dos Santos (0000-0002-5528-0658, Universidade Federal do Espírito Santo), Ingridy M P Barbalho (0000-0001-5696-4114, Universidade Federal do Rio Grande do Norte), Michael Ruberson Ribeiro Da Silva (0000-0003-2550-7249, Universidade Federal do Espírito Santo)
Year2024
Volume20
Pagese2011
Publication date2024-02-20
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueHygeia - Revista Brasileira de Geografia Médica e da Saúde (JOURNAL)
Journal identifiersISSN: 1980-1726 • E-ISSN: 1980-1726
PublisherPPUFU - Portal de Periódicos da Universidade Federal de Uberlândia (PUBLISHER)
DOI10.14393/hygeia2068984
OpenAlexW4392221304
LanguagePT
References cited14

Objective: To estimate the consumption and expenses with the Specialized Pharmaceutical Assistance Component (CEAF) in Brazil. Methods: A time series study was carried out, based on data on consumption and expenditure on CEAF medicines in Brazil, from 2012 to 2021. Data from this study were extracted through the Ambulatory Information System of the System Health System (SIA/SUS) and the Information System on Public Health Budgets (SIOPS). Results: Important differences were identified in the accounting of CEAF drug expenditures by SIA/SUS and SIOPS, and SIA/SUS expenditures were underestimated in relation to those recorded in SIOPS. According to the SIA/SUS, the Southeast region had the highest expenditure on CEAF medicines, followed by the South, Northeast, Midwest and North regions. In addition, when checking the quantities of pharmaceutical units purchased, a gradual increase was observed over the years (2012 - 2021). Conclusion: Spending on CEAF drugs has remained stable over the years. On the other hand, it was observed that, over the years, there was an increase in the number of pharmaceutical units acquired, verifying a better application of public resources among the federal entities

Medicine · Public Health in Brazil

Tools

Open DOIOpen Access